Ribonucleotide Reductase Expression in Cervical Cancer-Reference-Cited by-同舟云学术

Ribonucleotide Reductase Expression in Cervical Cancer

Published:2013-05 Issue:4 Volume:23 Page:615-621
ISSN:1048-891X
Container-title:International Journal of Gynecological Cancer
language:en
Short-container-title:International Journal of Gynecological Cancer

Author:

Kunos Charles A.,Winter Kathryn,Dicker Adam P.,Small William,Abdul-Karim Fadi W.,Dawson Dawn,Jhingran Anuja,Valicenti Richard,Weidhaas Joanne B.,Gaffney David K.

Publisher

BMJ

Subject

Obstetrics and Gynaecology,Oncology

Reference33 articles.

1. Modulating Radiation Resistance by Inhibiting Ribonucleotide Reductase in Cancers with Virally or Mutationally Silenced p53 Protein

2. Ribonucleotide Reductase Inhibition Enhances Chemoradiosensitivity of Human Cervical Cancers

3. Radiosensitization of Human Cervical Cancer Cells by Inhibiting Ribonucleotide Reductase: Enhanced Radiation Response at Low-Dose Rates

4. Deoxynucleoside Salvage Facilitates DNA Repair During Ribonucleotide Reductase Blockade in Human Cervical Cancers

5. Phase I Trial of Pelvic Radiation, Weekly Cisplatin, and 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, NSC #663249) for Locally Advanced Cervical Cancer

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploiting somatic alterations as therapeutic targets in advanced and metastatic cervical cancer;Cancer Treatment Reviews;2021-07

2. Radiopharmaceutical Validation for Clinical Use;Frontiers in Oncology;2021-03-03

3. Novel Radiosensitization Strategies in Uterine Cervix Cancer;Seminars in Radiation Oncology;2020-10

4. Brachytherapy Future Directions;Seminars in Radiation Oncology;2020-01

5. Randomized Phase II Trial of Triapine-Cisplatin-Radiotherapy for Locally Advanced Stage Uterine Cervix or Vaginal Cancers;Frontiers in Oncology;2019-10-15